Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
2
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
life sciences
national
national blog main
national top stories
2
×
new york blog main
new york top stories
novartis
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
abbvie
accent therapeutics
aducanumab
allergan
alzheimer's disease
amblyotech
amgen
anemia
What
bio
fda
2
×
roundup
2
×
activity
approvals
august
biogen
biotech
busy
clamped
covid
days
decisions
delays
developing
devices
drugs
economic
fast
including
ipo
isn’t
legacy
lot
medicines
new
news
nods
opioid
oric’s
past
regulatory
sarepta’s
seven
shkreli’s
showing
slow
spread
stumble
suits
Language
unset
Current search:
roundup
×
fda
×
biogen
×
" national top stories "
×
novartis
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More